Summary
Purpose of this study was to assess the clinical value of sestamibi whole body scintigraphy in detecting local recurrences and metastases in patients with differentiated thyroid carcinoma and to compare these results with diagnostic 131-radioiodine scans and serum thyroglobulin determinations. 75 patients — following all total thyroidectomy and high dosed radioiodine therapy — underwent sestamibi and diagnostic iodine scintigraphy. In addition, serum thyroglobulin levels were determined. Only patients with elevated thyroglobulin levels showed positive sestamibi and/or iodine uptake. In comparison with iodine scans sestamibi scintigraphy revealed with a higher sensitivity recurrences and metastases especially in follicular and Htirthle cell carcinoma.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Aktolun C., Bayhan H.,Kir M. Clinical experience with 99m-Tc-MIBI imaging in patients with malignant tumors: preliminary results and comparison with 201-thallium. Clin Nucl Med 1992: 17: 171–176
Balone HR. Fink-Benett D, Stoffer SS. 99mTechnetium-sestamibi uptake by recurrent Hürthle cell carcinoma of the thyroid. J Nucl Med 1992; 33: 1393–1395
Dadparvar S.,Kirshna L.,Brady LW, et al. The role of 131-iodine-Na and 201-thallium imaging and serum thyroglobulin in the management of differentiated thyroid carcinoma. Cancer 1993; 71: 3767–3773
Aktolun C., Bayhan H.,Kir M. Clinical experience with 99m-Tc-MIBI imaging in patients with malignant tumors: preliminary results and comparison with 201-thallium. Clin Nucl Med 1992: 17: 171–176
Dadparvar S, Chevres A, Tulchinsky M, Kirshna-Badrinath L, Khan a, Slizofski W.Clinical utility of Tc-99m methoxisobutylisonitrile imaging in differentiated thyroid carcinoma: comparison with thallium-201 and iodine-131 Na scintigraphy, and serum thyroglobulin quantitation. Eur J Nucl Med 1995; 22: 1330–1338
Lastoria S, Vergara E, Varrella P, et al. Imaging of differentiated thyroid tumors with99m Tc (V) DMSA J Nucl Med 1993; 34: 12 p
Ramanna L, Waxman A, Braunstein G. 201 Thallium scintigraphy in differentiated thyroid cancer: comparison with radioiodine scintigraphy and serum determinations. J Nucl Med 1991; 32: 441–446
Wackers FJT, Berman DS, Maddahi J, et al. 99m Technetium hexakis 2 methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to 201-thallium for myocardial perfusion imaging. J Nucl Med 1989; 30: 301–311
Waxman AD. Non-cardiac uses of 201-thallium and 99m-Tc-sestamibi. Clinical nuclear medicine. Harvard Medical School Annual Lectureship, 1994, p86–86
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Basel AG
About this chapter
Cite this chapter
Meyer, G., Kleine, U., Tiling, R., Stein, K., Hahn, K. (1997). Tc-99m-Sestamibi Whole Body Scintigraphy: An Useful Tool in the Follow up of Patients with Differentiated Thyroid Carcinoma?. In: Bergmann, H., Kroiss, A., Sinzinger, H. (eds) Radioactive Isotopes in Clinical Medicine and Research. Advances in Pharmacological Sciences. Birkhäuser, Basel. https://doi.org/10.1007/978-3-0348-7772-5_11
Download citation
DOI: https://doi.org/10.1007/978-3-0348-7772-5_11
Publisher Name: Birkhäuser, Basel
Print ISBN: 978-3-0348-7774-9
Online ISBN: 978-3-0348-7772-5
eBook Packages: Springer Book Archive